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Summary 
The X-ray crystal structure of the high affinity complex 
between the pleckstrin homology (PH) domain from 
rat phospholipase C-S, (PLC-8,) and inositol-(1,4,5)- 
trisphosphate (lns(1 ,4,5)P3) has been refined to 1.9 A 
resolution. The domain fold is similar to others of 
known structure. Ins(1 ,4,5)P3 binds on the positively 
charged face of the electrostatically polarized domain, 
interacting predominantly with the 91152 and 93194 
loops. The 4- and 5-phosphate groups of Ins(l,4,5)P3 
interact much more extensively than the l-phosphate. 
Two amino acids in the PLC-6, PH domain that contact 
Ins(1 ,4,5)P3 have counterparts in the Bruton’s tyrosine 
kinase (Btk) PH domain, where mutational changes 
cause inherited agammaglobulinemia, suggesting a 
mechanism for loss of function in Btk mutants. Using 
electrostatics and varying levels of head-group speci- 
ficity, PH domains may localize and orient signaling 
proteins, providing a general membrane targeting and 
regulatory function. 
Introduction 
Pleckstrin homology (PH) domains are structural modules 
of around 120 amino acids that appear to be important for 
membrane association of proteins involved in intracellular 
signaling and the cytoskeleton (Gibson et al., 1994). Struc- 
tural studies have shown that they share a common archi- 
tecture, consisting of a 6 sandwich closed off at one end by 
aC-terminala helix(Ferguson etal., 1995). Eachdomainis 
also electrostatically polarized, with a positively charged 
region that coincides with the most variable face of the 
domain (Ferguson et al., 1994). A number of lines of evi- 
dence suggest that PH domains bind to phosphoinositides 
and their head groups. Harlan et al. (1994) showed that 
the N-terminal PH domain from pleckstrin binds to deter- 
gent-solubilized phosphatidylinositol-(4,5)-bisphosphate 
(Ptdlns(4,5)Pz). This interaction occurs with low affinity (ffi 
= 30 PM), and little stereo specificity is evident. Hyvijnen 
et al. (1995) have also reported weak binding of the 
6-spectrin PH domain to inositol-(1,4,.5)-trisphosphate 
(lns(1 ,4,5)P3). The & for this interaction was >40 PM, and 
only limited specificity was demonstrated. In both cases, 
structural studies showed that the phosphoinositide inter- 
acts with the positively charged face of the PH domain 
(Harlan et al., 1994; Hyvonen et al., 1995). In neither of 
these cases, however, is there any evidence for the physio- 
logical relevance of the interaction studied. 
Studies aimed at identifying cytoplasmic Ins(l ,4,5)P3- 
binding molecules led Kanematsu et al. (1992) to clone 
phospholipase C-S, (PLC-S,). Like other PLC isoforms, 
PLC-6, has a PH domain at its N-terminus (Parker et al., 
1994), and this region has been implicated in the stereo- 
specific binding of both Ins(1 ,4,5)P3 and Ptdlns(4,5)P2 to 
PLC-S, (Cifuentes et al., 1993, 1994; Yagisawa et al., 
1994). The isolated PLC-S, PH domain (PLCSPH) has 
since been shown to bind lns(1,4,5)P3 with high affinity 
(Kd = 210 nM) in a stereo-specific manner (Lemmon et 
al., 1995). It also binds to Ptdlns(4,5)P2 in phospholipid 
vesicles (& = 1.7 PM). It has been proposed that the PH 
domain of PLCB, serves to anchor the enzyme to 
Ptdlns(4,5)Pz-rich membranes, permitting processive or 
scooting mode hydrolysis of substrate (Lemmon et al., 
1995; Rebecchi et al., 1992; Cifuentes et al., 1993; Rami- 
rez and Jain, 1991). Ins(1 ,4,5)P3 binding to the PH domain 
competes with Ptdlns(4,5)P2 binding (Lemmon et al., 1995) 
and inhibits the activity of PLC-S, (Kanematsu et al., 1992; 
Cifuentes et al., 1994). Studies of other PH domains, in- 
cluding those from 6-adrenergic receptor kinase (Pitcher 
et al., 1995), Bruton’s tyrosine kinase (Btk) (Li et al., 1995) 
insulin receptor substrate 1 (IRS-l) (Myers et al., 1995; 
Voliovitch et al., 1995), and the guanine nucleotide-releas- 
ing factor SOS (for Son of sevenless; McCollam et al., 1995) 
all indicate that a membrane anchoring function may rep- 
resent a general role. The present challenge is to deter- 
mine whether such anchoring can arise from weak, rela- 
tively unspecific interactions such as those seen for the 
PH domains from pleckstrin and spectrin, or requires high 
affinity, stereo-specific binding such as that seen for 
PLCSPH. 
In our efforts to understand the basis for the specificity 
and high affinity of PLCSPH for Ins(l,4,5)P3, we have de- 
termined the X-ray crystal structure of the PLCSPH- 
Ins(1 ,4,5)P3 complex at 1.9 A resolution. This is the most 
clearly physiologically relevant and most stable complex 
reported for a PH domain. PLCSPH has the same architec- 
ture and electrostatic polarization as other PH domains, 
and Ins(l,4,5)P3 is bound to the positively charged surface 
of the domain. Two residues that contact Ins(1 ,4,5)P3 have 
counterparts in the Btk PH domain at which mutational 
changes cause inherited agammaglobulinemia (Rawlings 
et al., 1993;Thomasetal., 1993;Vihinenet al., 1995).This 
suggests that elements of the PH domain-phosphoinositol 
interactions seen in this study may have broad implica- 
tions for the function of PH domains in general. 
Results and Discusslon 
PLCSPH, corresponding to residues 1 l-l 40 of rat PLC-S,, 
was produced in Escherichia coli and purified as described 
(Lemmon et al., 1995). Crystals of the unliganded PH do- 
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Figure 1. Overall Fold and Electrostatic Polarization of the PLCGPH-lns(1 ,4,5)P3 Complex 
(A) A RIBBONS (Carson, 1991) representation of amino acids 12-130 of PLCGPH in complex with lns(1,4,5)P,, viewed perpendicular to the two 
b sheets. Ins(1 ,4,5)Pa is shown in magenta in a ball-and-stick representation. 
(B) A RIBBONS (Carson, 1991) representation of the PH domain from human dynamin (DynPH) (Ferguson et al., 1994) in the same orientation 
as that seen for PLCGPH in (A). 
(C) Polarized electrostatic potential of PLCGPH calculated without the bound Ins(1 ,4,5)P3, contoured at +2 kT (red) and -2 kT (blue). The orientation 
of PLCGPH is as for (A). This polarization of the electrostatic potential is conserved in other PH domains of known structure (Ferguson et al., 
1995). 
main could not be obtained, whereas tetragonal crystals 
(P432,2; a = 59.2 A, c = 80.7 A) could be grown from 
hanging drops of a PLCGPH:lns(l ,4,5)P3 (1 .0:1.2) mixture 
with 12% PEG 20,000 as the precipitant. Crystals grew 
to a typical size of 0.06 x 0.06 x 0.8 mm in 3 days at 18% 
and diffracted X-rays to better than 1.9 A at the National 
Synchrotron Light Source (NSLS) X25 beamline. To solve 
the structure, phases were determined by multiple isomor- 
phous replacement plus anomalous scattering using a 
mercury derivative and crystals of selenomethionine (Se- 
Met)-containing protein (see Experimental Procedures; 
Table 1). The position of the bound Ins(1 ,4,5)P3wasclearly 
interpretable in initial experimental electron density maps. 
Solvent flattening, histogram matching, and partial model 
combination were employed to improve phases, permit- 
ting clear interpretation of amino acids 12-130 of PLC-& 
as well as the lns(1,4,5)P3 in the electron density map. 
The resulting model was refined to afinal R factorof 20.5% 
(>20 data) with 110 water molecules included. A Rama- 
chandran plot showed no violators of accepted backbone 
torsion angles, and the model has good geometry (Ta- 
ble 1). 
Structure of PLCGPH 
The overall architecture of PLCSPH is similar to that of 
other PH domains (Saraste and Hyviinen, 1995). Figure 1 
showsaviewof the PLCGPH-lns(1 ,4,5)P3complex(Figure 
1A) alongside a view of the dynamin PH domain (Figure 
16) (Ferguson et al., 1994) for comparison. Each PH do- 
main is a 5 sandwich closed off at one of its splayed corners 
(Chothia, 1984) by a C-terminal u helix. PLCSPH contains 
two additional short a helices not found in other PH do- 
mains: one is at the N-terminus, and the other is in the 
65/p6 loop, and neither directly contacts the bound 
Ins(1 ,4,5)P3. The spectrin PH domain also contains an ad- 
ditional a helix, in the f33/64 loop (Macias et al., 1994). In 
view of the very weak sequence identity, the structural 
similarity with other PH domains is remarkable. PLCGPH 
shares only around 10% sequence identity with the other 
domains of known structure. 
Like other PH domains (Macias et al., 1994; Ferguson 
et al., 1994, 1995) PLCGPH shows marked electrostatic 
sidedness (Figure 1 C). The positively charged faces of the 
PH domains from dynamin and spectrin were previously 
invoked as a likely surface for interaction with negatively 
charged membrane surfaces (Ferguson et al., 1994; Gib- 
son et al., 1994). This surface coincides with the segments 
of PH domains that exhibit the greatest sequence variabil- 
ity, supporting the suggestion that the positive face also 
determines the specificity. As described below, the bind- 
ing site for Ins(1 ,4,5)P3 is in the center of this positively 
charged region on the surface of PLCSPH, at the splayed 
corner of the 5 sandwich opposite the C-terminal a helix 
(Figures 1A and 1C). 
Ins(1 ,4,5)P3 Binding to PLCGPH 
The amino acids that interact with Ins(1 ,4,5)P3 are mostly 
in the 61162 and 63164 loops of PLCSPH (Figures 2 and 
3A). Direct hydrogen bonds are seen between the bound 
Ins(l,4,5)P3 and seven amino acids, as seen in Figure 3. 
Two lysine side chains, K30 and K57, appear to clamp the 
4- and 5-phosphate groups of Ins(1 ,4,5)P3 in the binding 
pocket, each hydrogen bonding with both phosphates 
(Figures 38 and 3C). These dual contacts suggest a ste- 
reochemical cooperativity of interactions that enhances 
specificity. Through additional interactions with the side 
chains of R40, S55, and the backbone NH of R56, plus 
a water-mediated hydrogen bond with the backbone car- 
bony1 of E54, the 5-phosphate of Ins(1 ,4,5)P3 is completely 
buried. The 4-phosphate forms hydrogen bonds directly 
to the side chains of K30, K32, and K57, and via a water 
molecule to the backbone carbonyl of T107. Although 
nearly all of the Ins(l,4,5)P,-PH domain interactions in- 
volve the 4- and 5-phosphate groups, our previous binding 
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20 30 40 50 60 Figure 2. Sequence Alignment and Compari- 
0 
son with Other PH Domains 
PLC delta 1 D s.. . . . . . ..ssw Structure-based sequence alignment of 
PLCGPH with the three other PH domains of 
known structure: human N-terminal pleckstrin 
PH domain (l-103) mouse brain spectrin PH 
domain (2199-2304) and human dynamin PH 
domain (506-629). An alignment of the Bru- 
ton’s tyrosine kinase (Btk) PH domain (1-136) 
is also shown. The elements of secondary 
structure of PLCGPH are shaded green for 6 
strands and blue for (I helices. The secondary 
structure elements that are conserved among 
PH domains are shown under the sequences. 
Amino acids in PLCGPH that contact 
lns(1,4,5)P, are indicated with the following 
symbols above the sequence (black for direct 
contacts, blue for water-mediated interactions): 
inverted triangle, contacts the Cphosphate; tri- 
angle, contacts the5phosphate; diamond, con- 
tacts both the 4- and 5-phosphate; circle, con- 
tacts the l-phosphate. Amino acids boxed in yellow in the spectrin, pleckstrin N-terminal, and dynamin PH domain sequences correspond to those 
positions implicated by NMR analysis in binding to lns(1 ,4,5)P3(Hyv6nen et al., 1995), Ptdlns(4,5)P2 (Harlan etal., 1994) and I-(o-glycerophosphoryl)- 
lns(4,5)P, (Zheng et al., 1996), respectively. Those boxed red in the spectrin PH domain sequence were seen to contact Ins(1 ,4,5)P3 in the crystal 
structure (Hyvdnen et al., 1995). The two positions of XLA mutations in BtkPH (Vihinen et al., 1995) that correlate with lns(1,4,5)P3 binding in 
PLCGPH are boxed in magenta, while the position of the activating mutation (Li et al., 1995) is shaded blue. 
analyses (Lemmon et al., 1995) showed that at least one 
additional phosphate is required. The structure suggests 
that additional phosphates could be accommodated at ei- 
ther the 1 or the 2 position. However, Ins(1 ,4,5)P3 binds 
23-fold more tightly to PLCGPH than does lns(2,4,5)P3 
(Lemmon et al., 1995), indicating that specific interactions 
involving the I -phosphate are more important for high af- 
finity binding than nonspecific electrostatic attraction. A 
direct hydrogen bond is seen between the l-phosphate 
of lns(1,4,5)P3 and the indole nitrogen of the W36 side 
chain, which is in van der Waals contact with part of the 
inositol ring (Figure 36). Here again, local cooperativity 
may enhance specificity; i.e., this inositol ring contact but- 
tresses lns(1,4,5)P3 for optimal interaction of its 4- and 
5-phosphates with the protein, and vice versa. In 
agreement with our previous studies, the structure shows 
that phosphates at the 3 or 6 positions would sterically 
interfere with inositol phosphate binding. 
The Binding Site for Ins(1 ,4,5)P3 Suggests 
Explanations for XLA Mutations 
A number of mutations in the PH domain of Bruton’s tyro- 
sine kinase (BtkPH) have been shown to cause X-linked 
agammaglobulinemia (XLA) (Thomas et al., 1993; Raw- 
lings et al., 1993; Vihinen et al., 1995). Although the physi- 
ological ligand for this PH domain is not yet known, the 
locations of several such natural mutations suggest that 
the functional surface of BtkPH is close to the Ins(1 ,4,5)P3- 
binding site on PLCGPH. XLA may therefore result from 
an impaired interaction of BtkPH with a ligand such as an 
inositol phosphate or similar compound. Two amino acids 
so implicated are analogous in sequence position and side 
chain type to those in PLCSPH that interact directly with 
Ins(1 ,4,5)P3. Substitution in BtkPH of F25 with serine or 
R28 with histidine results in XLA. These amino acids corre- 
spond to W36 and R40 in PLCGPH (see Figure 2) which 
form hydrogen bonds to the l- and 5-phosphates of 
Ins(l,4,5)P3, respectively, and van der Waals contact with 
the inositol (W36). Changes analogous to the XLA muta- 
tions at either position in PLCGPH would be likely to reduce 
affinity for Ins(1 ,4,5)P3. A gain-of-function mutation has 
also been observed in BtkPH (E41 K) (Li et al., 1995) that 
can cause transformation of NIH 3T3 cells and results 
in enhanced membrane localization of whole Btk. E41 in 
BtkPH is the counterpart of E54 in PLCGPH, which is in 
the 83@4 loop. The backbone carbonyl of E54 in PLCGPH 
contacts the 5-phosphate of Ins(1 ,4,5)P3 through a water- 
mediated hydrogen bond. Substitution with a basic amino 
acid at this position could enhance binding to a phospho- 
inositide or similar ligand and result in the observed gain 
of function. 
Comparison with Low Affinity Binding 
of Phosphoinositides to Ot’her PH Domains 
Ins(l,4,5)P3 binding to the PH domain from spectrin (Hy- 
v&en et al., 1995) is at least 200-fold weaker (K,, > 40 
FM) than its binding to PLCSPH (& = 210 nM). Similarly, 
Ptdlns(4,5)P, binds to the N-terminal pleckstrin PH domain 
with a lG of approximately 30 f.rM (Harlan et al., 1994), 
while l-(a-glycerophosphoryl)-lns(4,5)P, binds weakly to 
the dynamin PH domain (Kd = 4.3 mM) (Zheng et al., 
1996). In each case, nuclear magnetic resonance (NMR) 
studies have identified amino acids in the PH domains that 
are involved in these interactions. In addition, Hyvdnen 
et al. (1995) have described the crystal structure of the 
Ins(l,4,5)Pz-spectrin PH domain complex. 
In an effort to understand the stereochemical basis for 
the higher stability of the PLCSPH-lns(1 ,4,5)P3 complex 
that we describe, we compare the interactions involved in 
phosphoinositide binding to each of the three PH domains. 
The amino acids implicated in each case are highlighted 
in Figure 2. Broadly, phosphoinositides and inositol phos- 
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Figure 3. The Ins(1 ,4,5)P3-Binding Site 
(A) RIBBONS diagram of the PLCSPH-lns(l ,4,5)P3 complex rotated 
approximately 90” around a vertical axis with respect to Figure 1A. 
The positions of amino acids that contact lns(1,4,5)P3 are labeled in 
yellow. 
(B) A stereo pair showing the details of the interactions between 
Ins(i ,4,5)P3and PLCGPH seen in the crystal structure. All the hydrogen 
bonds seen to the Ins(1 ,4,5)P3 are shown with dashed lines. Water 
molecules are represented by small red spheres. Only side chains 
that form hydrogen bonds with lns(1,4,5)P3 are included. 
(C) Stereo pair of a 2F.-F, electron density map contoured at 2.00. 
For clarity, only selected hydrogen bonds are shown. This view shows 
the two lysines, K57 and K30, which can be described as clamping 
the 4- and 5phosphates in the binding pocket (see Figure 38). 
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Figure 4. Comparison of lns(1,4,5)P3 Binding 
to PLCGPH and the Spectrin PH Domain 
(A) A schematic representation of hydrogen 
bonds formed between lns(1,4,5)P3 and 
PLCGPH (see also Figure 38). 
(6) Representation of the relationship of 
tns(1,4,5)P, to thesurfaceof PLCSPH,showing 
how portions of Ins(l ,4,5)P3 project into a cav- 
ity. A solvent-accessible surface is shown 
around the protein. The 4- and 5-phosphates 
can be seen behind the partially transparent 
representation of the protein surface. The ori- 
entation shown is the same as that in Figure 
IA. 
(C) A representation of Ins(1 ,4,5)P3 bound to 
the surface of the spectrin PH domain, shown 
in an orientation similar to that in (B). 
lns(1 ,4,5)P3 is seen to bind in a different loca- 
tion from its binding site on PLCSPH (see text), 
with a different orientation and little penetration 
into any cavity on the protein surface. Coordi- 
nates for the spectrin PH domain-lns(l,4,5)P3 
complex were provided by Mathias Wilmanns 
of EMBL and were used, with permission, to 
generate (C) (Hyvdnen et al., 1995). 
phates bind to the same side of each PH domain, in the 
region of the pllp2 loop. The binding site is in the middle 
of the positively charged face of each electrostatically po- 
larized PH domain (Ferguson et al., 1995). The proposed 
phosphoinositide-binding sites on the pleckstrin and dy- 
namin PH domains coincide approximately with the site of 
Ins(l,4,5)Ps binding to PLCGPH (Figure 3A). Amino acids 
implicated in binding are in the region of the fi1/82 and 
33/(34 loops in each case (Harlan et al., 1994; Zheng et 
al., 1996). The Ins(1 ,4,5)P3-binding site on the spectrin PH 
domain, by contrast, occurs on the opposite side of the 
61@2 loop, and additional interactions are contributed 
largely by the 65/(36 loop (Hyvbnen et al., 1995). This dis- 
placement of the binding site on the spectrin PH domain 
correlates with the altered position of its positively charged 
face (Ferguson et al., 1995). 
A detailed comparison of the interactions with 
Ins(1 ,4,5)P3 is only possible with the spectrin PH domain, 
for which the crystal structure of the complex is known 
(HyvBnen et al., 1995). There are large differences in the 
number and arrangement of interactions that are likely to 
account for the 200-fold higher stability of the complex 
formed between Ins(1 ,4,5)P3 and PLCGPH. Seven hydro- 
gen bonds, involving five amino acids, form between 
Ins(1 ,4,5)P3 and the spectrin PH domain, while there are 
12 hydrogen bonds involving nine amino acids between 
Ins(1 ,4,5)P3 and PLCGPH (Figure 4A). The starkest con- 
trast is seen for the 5-phosphate of Ins(1 ,4,5)P3, which is 
involved in three hydrogen bonds to two amino acids in the 
spectrin PH complex, but participates in seven hydrogen 
bonds to six amino acids in the PLCGPH complex. The 
number of interactions between the 5-phosphate and 
PLCGPH is thus greater than that seen between the entire 
Ins(l,4,5)P3 molecule and the spectrin PH domain. Further 
differences between the modes of Ins(1 ,4,5)P3 binding to 
the two PH domains can be seen in interactions involving 
the inositol ring. One side of the inositol ring of Ins(1 ,4,5)P3 
bound to PLCGPH is in van der Waals contact with the 
aliphatic portion of the K32 side chain and the side chain 
of W36, which is in turn is held in position by its interaction 
with the l-phosphate of Ins(1 ,4,5)P3. By contrast, in bind- 
ing to the spectrin PH domain, the inositol ring of 
Ins(1 ,4,5)P3 is not in close contact with the protein. Indeed, 
as can be seen in a comparison of Figures 48 and 4C, 
Ins(1 ,4,5)P3 is significantly more buried within a binding 
pocket in the PLCGPH-lns(1 ,4,5)P3 complex (Figure 4B) 
than in the spectrin PH domain-lns(l,4,5)P3 complex. 
Ins(l,4,5)P3 appears to lie on the surface of the spectrin 
PH domain, its phosphate groups interacting with surface- 
located side chains (Figure 4C). 
A unique feature of PLCGPH that could contribute fur- 
ther to its high affinity for Ins(1 ,4,5)P3 is the position of the 
63/(34 loop, which is intimately involved in ligand binding 
(see Figure 3A). In the dynamin PH domain (Ferguson et 
al., 1994; Fushman et al., 1995), and others of known 
structure (Macias et al., 1994; Yoon et al., 1994), this loop 
projects away from the plane of strands 61 to 64 (Figure 
56). By contrast, in the PLCGPH-lns(1 ,4,5)P3 complex, 
the f33/64 loop remains in this plane and extends toward 
the ligand (Figure 5A). This difference in the position of 
a loop that makes significant contact with the ligand may 
help explain the much higher affinity shown by PLCSPH 
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Figure 5. A Possible Conformational Change upon Ligand Binding 
Ca-trace, viewed down the long axis of the C-terminal o helix, of PLCGPH (A) and DynPH (B). The p3/54 loop, which is in a different orientation 
in the PLCGPH-lns(l,4,5)P3 complex compared with other unliganded PH domains (see text), is co!ored green. The root-mean-square deviation 
between the backbone of the core elements of secondary structure of PLCGPH and DynPH is 1.75 A (amino acids aligned between PLCSPH and 
DynPH are the following: 25-32 and 15-22,37-44 and 30-37, 50-54 and 41-45, 65-69 and 55-59, 73-77 and 62-66,95-101 and 76-82, and 
109-l 29 and 96-116). 
for Ins(1 ,4,5)P3. Without the unliganded PLCSPH structure 
for comparison, however, we can only speculate on the 
origin of this difference. It is possible that the difference 
in position of the f33/54 loop reflects a conformational 
change in PLCSPH upon ligand binding, one reminiscent 
of the change seen in streptavidin upon biotin binding (We- 
ber et al., 1989). No such conformational changes are 
seen upon binding of lns(1,4,5)P3 to the spectrin PH do- 
main (Hyvbnen et al., 1995). Their occurrence in PLCSPH 
could contribute to the higher binding affinity. 
Implications for PH Domain Ligand Recognition 
The major challenge in studies of PH domains is to estab- 
lish the physiological relevance of the ligand-binding inter- 
actions that have been reported. PLC-S, was cloned as 
a result of experiments aimed at identifying lns(1,4,5)P3 
receptors in rat brain cytosol (Kanematsu et al., 1992). 
Ins(1 ,4,5)P3 is the head group of the preferred substrate 
for PLC-S, and was clearly found to be the preferred ligand 
for PLCSPH in our previous studies (Lemmon et al., 1995). 
lns(1,4,5)P3 binding to PLCSPH is just 5-fold weaker 
than its binding to the purified endoplasmic reticulum 
lns(1,4,5)P3 receptor (K,, = 40 nM) (Ferris et al., 1989). 
Furthermore, lns(1,4,5)P3 has been shown to inhibit 
PLC-6, activity in vitro by reducing the affinity of the en- 
zyme for substrate-rich membranes (Cifuentes et al., 
1994; Yagisawa et al., 1994). Proteolytic removal of a por- 
tion of the PH domain from PLC-61 abolishes these effects 
and itself reduces the affinity of the enzyme for 
Ptdlns(4,5)P2-containing membranes (Cifuentes et al., 
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1993,1994; Yagisawaet al., 1994). It is therefore likelythat 
D-myO-hTS(l ,4,5)P3 represents a physiologically relevant 
ligand for PLCGPH. The stereospecific character of this 
interaction is indicated in our previous studies of specificity 
of ligand binding, which showed that any change in the 
arrangement or number of phosphate groups leads to at 
least a 15fold reduction in the affinity of the inositol phos- 
phate for PLCSPH (Lemmon et al,, 1995). The PLCGPH- 
Ins(1 ,4,5)P3 interface seen in the crystal structure provides 
a stereochemical explanation for this. 
It is possible that the binding sites for phosphoinositides 
that have been located by NMR and crystallographic stud- 
ies of the PH domains from spectrin, pleckstrin, and dy- 
namin reflect limited interactions with noncognate ligands 
(Harlan et al., 1994; Hyvbnen et al., 1995; Zheng et al., 
1996). The strongest of these interactions has a Kd of 30 
FM (Harlan et al., 1994) while all inositol polyphosphates 
tested (with three or more phosphates) bind to PLCGPH 
with Kd values of 13 uM or less (Lemmon et al., 1995). 
Therefore, the interactions of PLCGPH with inositol phos- 
phates against which it discriminates are still stronger than 
those seen in studies of any other PH domain. This fact, 
together with a lack of functional relevance, argues that 
the physiological importance of phosphoinositide or inosi- 
tol phosphate binding to the PH domains of spectrin, pleck- 
strin, and dynamin must be questioned. The physiologi- 
cally relevant ligands for these other PH domains, if such 
ligands exist, may be molecules other than inositol poly- 
phosphates that contain phosphate groups or other nega- 
tively charged moieties. 
It is also possible that the other PH domains do not 
have highly specific strongly interacting ligands, and that 
PLCGPH is a special case. The positively charged face of 
PH domains is likely to be important for their binding to 
anionic membrane surfaces (Ferguson et al., 1994,1995; 
Hyviinen et al., 1995). This could involve delocalized elec- 
trostatic attraction between the protein and the membrane 
surface, as shown for secretory phospholipase AP mole- 
cules (Scott et al., 1994). Binding to Ptdlns(4,5)P2 or other 
phosphoinositides could serve to augment this electro- 
static interaction, while also imposing some stereospeci- 
ficity. PLCSPH binds to Ptdlns(4,5)P2 in vesicles 6-fold 
more weakly (& = 1.7 PM) than it does to its soluble 
head-group Ins(1 ,4,5)P3. This may result from a reduction 
in the degrees of freedom or accessibility (or both) of the 
head group in the lipid bilayer (Figure 6). The diminished 
affinity for the phospholipid head group under these condi- 
tions may be partly compensated for by delocalized elec- 
trostatic attraction between the protein and the membrane 
surface. This suggestion is strengthened by the fact that 
binding of whole PLC-8, to Ptdlns(4,5)P,-containing mem- 
branes is enhanced by the presence of other anionic lipids 
(Rebecchi et al., 1992). Furthermore, PLCGPH binds to 
Ptdlns(4)P in negatively charged lipid vesicles with a Kd 
of approximately 15 PM, while it does not interact with the 
soluble head group of this phospholipid, Ins(1 ,4)Pz (Lem- 
mon et al., 1995). 
Following these arguments, binding of the pleckstrin PH 
domain to Ptdlns(4,5)P,-containing vesicles (Harlan et al., 
C 
Figure 6. Schematic Representation of PLCGPH Binding to 
Ptdlns(4,5)P2 in a Membrane 
PLCGPH is shown in a ribbon representation in the same orientation 
as in Figure IA and Figure 2. Ins(1 ,4,5)P3 is shown bound to PLCGPH 
as seen in the crystal structure. Diacylglycerol has been attached to 
the lns(1,4,5)P, to give an impression of the way Ptdlns(4,5)P2 might 
associate with PLCGPH. The Ptdlns(4,5)P2 molecule is shown in a 
highly schematized bilayer. The positive face of the PLCGPH (Figure 
1 C) faces the membrane. This figure was generated with MOLSCRIPT 
(Kraulis, 1991). 
1994) could result primarily from the electrostatic interac- 
tion between the membrane surface and the positively 
charged face of the PH domain. We have been unable to 
detect significant interactions between the pleckstrin PH 
domain and Ins(1 ,4,5)P3 (Lemmon et al., 1995), which sup- 
ports this suggestion. The spectrin PH domain binds with 
high affinity to stripped bovine brain membranes (Davis 
and Bennett, 1994; Lombard0 et al., 1994). The binding 
to lns(1,4,5)Pa reported by Hyvijnen et al. (1995) is not 
sufficiently tight to explain this observation, but could aug- 
ment and provide some stereo specificity to a delocalized 
electrostatic interaction with the membrane surface. 
Functional Implications 
By anchoring PLC-& to substrate-containing membranes, 
interaction of PLCGPH with Ptdlns(4,5)P2 (Lemmon et al., 
1995) may allow processive substrate hydrolysis by the 
enzyme (Cifuentes et al., 1993, 1994; Kanematsu et al., 
1992). The product of this hydrolysis, Ins(1 ,4,5)P3, com- 
petes with Ptdlns(4,5)P2 for binding to PLCSPH and re- 
duces the affinity of PLCd, for Ptdlns(4,5)P2-containing 
membranes (Cifuentes et al., 1994). This inhibits the en- 
zyme (Kanematsu et al., 1992), suggesting that product 
inhibition could be important in PLC-6, regulation, and that 
the PH domain is required for this effect. Most PH domains 
are found in proteins that require membrane association 
for their function, such as the 6-adrenergic receptor kinase 
(Pitcher et al., 1995) guanine nucleotide-releasing fac- 
tors, and protein kinases (Gibson et al., 1994). All PH do- 
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mains may have phosphoinositide-like ligands and may 
be subject to regulated membrane association as de- 
scribed for PLC-S,. The physiological relevance of the low 
affinity interactions of PH domains with phosphoinositides 
and their head groups remains to be determined. Analysis 
of the interactions between Ins(l,4,5)Pa and PLCSPH 
shows acorrespondence between amino acids in PLCSPH 
that contact Ins(1 ,4,5)P3 and those in BtkPH at which muta- 
tional changes alter function. This suggests that the struc- 
ture presented here can serve as a valuable model for 
further analysis of PH domain structures and functional 
interactions with their ligands. 
Experimental Procedures 
Preparation and Crystallization of PLCSPH 
PLCGPH, corresponding to residues 1 l-140 of rat PLC-6,, was pro- 
duced in Escherichia coli by using a T7 expression system and was 
purified by cation exchange and size-exclusion chromatography as 
previously described (Lemmon et al., 1995). Following gel filtration, 
the protein was concentrated and buffer exchanged for a further hy- 
droxyapatite purification step. Protein was loaded on to a2 ml column 
of Macro-Prep ceramic hydroxyapatite (Bio-Rad Laboratories, Incorpo- 
rated) equilibrated with 10 mM Na/K phosphate, 10% glycerol, 0.5 
mM CaClz (pH 7.0) and was eluted by running a Na/K phosphate con- 
centration gradient from 10 to 200 mM. The resulting material was at 
least 99% pure as assessed on overloaded silver-stained SDS gels. 
D-myo-lns(1 ,4,5)P3 was purchased from Sigma and used without fur- 
ther purification. PLCGPH was concentrated by ultrafiltration and 
buffer exchanged with 25 mM NaCI, 10% glycerol, 10 mM morpholine- 
ethanesulfonic acid (MES) (pH 6.5). Protein concentration was deter- 
mined by measurement of OD,,,, using the calculated extinction coeffi- 
Table 1. Summary of Crystallographic Data 
Data Collection Statistics 
Number of Heavy 
Source Resolution Limit (A) Rs,,” P/o) Completeness(%) Atom Sites 
Native R-Axis II 2.4 9.2 96.5 
Se-Met NSLS X25 1.9 6.4 99.6 2 
HgCI, Xentronics 2.6 6.0 89.1 2 major, 3 minor 
Phasing Statistics 
Resolution (A) 15-9.06 6.49 5.05 4.14 3.50 3.04 2.68 2.4 Overall 
Phasing powerb 
HgCI, isomorphous 2.92 2.87 2.94 2.08 1.51 1.54 1.70 - 1.91 
HgClz anomalous 0.63 0.53 0.53 0.50 0.41 0.31 0.27 - 0.40 
Se-Met isomorphous 1.01 0.93 0.78 0.56 0.37 0.34 0.38 0.29 0.41 
Se-Met anomalous 0.34 0.43 0.52 0.45 0.45 0.40 0.41 0.41 0.43 
Mean figure of merit” 0.62 0.70 0.67 0.57 0.45 0.34 0.30 0.20 0.37 
Refinement Statistics 
Resolution (A) 8.00-3.69 2.98 2.62 2.38 2.22 2.09 1.99 1.90 Overall 
Unique reflections 1554 1491 1476 1441 1449 1441 1423 1420 11695 
<I/o> 26.5 24.8 18.9 16.3 13.8 12.3 6.8 5.1 20.3 
R factor, all datad 17.2 17.7 22.9 24.5 24.5 25.4 28.3 30.7 21.3 (30.2) 
R factor, >2.0a datad 17.1 17.5 22.1 23.4 23.3 23.9 26.1 27.3 20.5 (29.1) 
Rms deviations 
Bond length (8) 0.008 
Bond angle (degrees) 1.48 
a Rs,, = &.lIh-lhll/Zh.lh., where 1 Ih-lhlJ is the absolute deviation of a reflection Ih. from the average Ih of its symmetry and Friedel equivalents (Friedel 
pairs were not merged for the Se-Met or HgCI, data sets). 
’ Phasing power = ZIFhcI/ZII\F,“I exp(i@,)+F,,c/-IF,h”l(r where lFhCl = heavy-atom structure factor, and jF,OI and lFpnOl are observed amplitudes 
for the protein and heavy-atom derivatives respectively, and & is the experimental phase. 
’ Figure of merit = j P(@)exp(i@)d@/jP(Q)d@ where P is the probability distribution of @, the phase angle. 
d Number in parentheses is the free R value (Briinger, 1992). 
cient. PLCSPH was then mixed with lns(1,4,5)P, in a 1.0:1.2 molar 
ratio (PLCSPH:lns(l ,4,5)P3) at a final protein concentration of 1.2 mM. 
Hanging drops were formed by mixing 3 ~1 of this complex with 3 cll 
of 12% PEG 20,000, 10% glycerol, 50 mM Na-citrate (pH 5.0) and 
were equilibrated by vapor diffusion against a reservoir of this solution. 
No crystals could be obtained under these conditions (or any other 
conditions tested) in the absence of Ins(1 ,4,5)P3. Tetragonal crystais 
of the PLCGPH-lns(l,4,5)P3 complex (P432,2; a = 59.4 A, 
c = 80.7 A) grew in three days at 18°C to a typical size of 0.06 x 
0.06 x 0.8 mm. Se-Met-containing protein was produced asdescribed 
previously (Ferguson et al., 1994). Crystals were stabilized in 20% 
PEG 20,000, 10% glycerol, 50 mM Na-citrate (pH 5.0), which also 
served as a cryosolvent. A single mercury derivative was obtained by 
soaking crystals in I mM HgCI, in this stabilizing solution for 12 hr. 
Data Collection and Structure Solution 
Data were collected at IOOK on crystals (stabilized in the cryosolvent) 
that had been flash-frozen in liquid nitrogen-cooled liquid propane. 
The native and HgCI,-derivative data were collected on an R-Axis II 
image plate detector and a Siemens Xentronics multiwire area detec- 
tor, respectively, in both cases using double mirror-monochromated/ 
focused Cu K, X-rays from a 0.2 mm focus of a Rigaku generator 
operating at 3 kW (50 kV x 60 mA). Data for crystals of Se-Met- 
containing protein were collected at the X25 beamline (NSLS) tuned 
to the Se absorption edge as determined for this crystal (a wavelength 
of 0.9 A), by use of a MAR image plate detector. R-Axis and X25 data 
were processed with DENZO (Otwinowski, 1993), while Xentronics 
data were processed with the program XDS (Kabsch, 1988a, 1988b). 
All data were scaled with SCALEPACK (Otwinowski, 1993). Two Se 
sites were located in the anomalous difference Patterson map calcu- 
lated from the Se-Met data set. The two major Hg sites in the HgClz 
derivative were found in isomorphous difference Fourier maps from 
the Se-Met-derived phases. A further three minor sites were found in 
the HgCI, derivative from isomorphous difference Fourier maps calcu- 
lated with phase information from both derivatives. The resulting heavy 
hll;$ Affinity PH Domain-lns(1 ,4,5)P3 Complex 
atom sites were refined, and phases were calculated with MLPHARE 
(Otwinowski, 1991). Solvent flattening, histogram matching, and par- 
tial model combination were employed to improve phases by use of 
DPHASE (G. Van Duyne). The program 0 (Jones et al., 1991) was 
used for all model building and adjustments, and the structure was 
refined with XPLOR (Brijnger, 1993). The final refined model includes 
amino acids 12-130 of PLC-&, plus lns(1,4,5)P3 and 110 water mole- 
cules A Ramachandran plot shows no violators of accepted backbone 
torsion angles. The crystallographic data are presented in Table 1. 
Figures IC, 48, and 4C were generated with the program GRASP 
(Nicholls and Honig, 1991). 
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